Molecular Pathogenesis and Interventional Strategies for Alzheimer's Disease: Promises and Pitfalls

Shashikala Bhute, Deepaneeta Sarmah, Aishika Datta, Pallavi Rane, Amit Shard, Avirag Goswami, Anupom Borah, Kiran Kalia, Kunjan R. Dave, Pallab Bhattacharya

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Alzheimer's disease (AD) is a debilitating disorder characterized by age-related dementia, which has no effective treatment to date. β-Amyloid depositions and hyperphosphorylated tau proteins are the main pathological hallmarks, along with oxidative stress, N-methyl-d-aspartate (NMDA) receptor-mediated excitotoxicity, and low levels of acetylcholine. Current pharmacotherapy for AD only provides symptomatic relief and limited improvement in cognitive functions. Many molecules have been explored that show promising outcomes in AD therapy and can regulate cellular survival through different pathways. To have a vivid approach to strategize the treatment regimen, AD physiopathology should be better explained considering diverse etiological factors in conjunction with biochemical disturbances. This Review attempts to discuss different disease modification approaches and address the novel therapeutic targets of AD that might pave the way for new drug discovery using the well-defined targets for therapy of the disease.

Original languageEnglish (US)
Pages (from-to)472-488
Number of pages17
JournalACS Pharmacology and Translational Science
Issue number3
StatePublished - Jun 12 2020


  • PrP
  • RanBP9
  • apolipoprotein
  • immune system
  • proteoglycans
  • sirtuins

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology


Dive into the research topics of 'Molecular Pathogenesis and Interventional Strategies for Alzheimer's Disease: Promises and Pitfalls'. Together they form a unique fingerprint.

Cite this